Advancing research and education for the use of microphysiological systems in drug discovery and development.

At Emulate, we believe the combination of human biology + technology can ignite a new era in health.

An era driven by human-relevant science.

An era when patients have the effective treatments they need.

An era when researchers are limited not by their research tools, but by the breadth of their imagination.

This is an era we are motivated to see in our lifetime. Global MPS Day is designed for members of the microphysiological systems community to learn, connect with peers, and share what motivates them to break new scientific ground.

Join us on March 9th, 2023, for a free, three-hour virtual symposium, where you will hear about the recent achievements made with MPS in cell and gene therapy, immunology, and cancer as well as a keynote speech from Dr. Robert Langer. You will also have the chance to join one of three breakout sessions focused on getting started with Organ-on-a-Chip technology.

Register for the Virtual Symposium


Keynote Speaker

Robert Langer, Sc.D.

Academic Co-Founder of Moderna and David H. Koch Institute Professor at Massachusetts Institute of Technology

The Edison of Medicine: Robert Langer’s Quest to Solve Global Health Challenges Using Biotechnology



Join the Discussion

Emulate invites the collective MPS community and drug discovery industries, individuals, and organizations to spark conversation on social media through a shared social media toolkit and #GlobalMPSDay hashtag.



Pay it Forward


To highlight the positive impact MPS can have on the world, we’re offering the global community a chance to give back. Registrants have until March 9th to choose from a group of organizations who share the vision of improving human health. The organization with the most votes will receive a $5,000 donation from Emulate.




“The MPS industry has seen monumental growth since the first Organ-on-a-Chip and MPS technologies were developed over a decade ago. Now that Congress and the White House have cracked the door open wider and invested deeper into the bioeconomy, it’s important for our industry to unify and showcase the full extent of our technological capabilities.”

Don Ingber, M.D., Ph.D.

Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University